Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. United States
  4. Nasdaq
  5. OpGen, Inc.
  6. News
  7. Summary
    OPGN   US68373L3078

OPGEN, INC.

(OPGN)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector news

OPGEN INC : Other Events, Financial Statements and Exhibits (form 8-K)

07/07/2021 | 05:23pm EDT

Item 8.01 - Other Events.

On July 7, 2021, OpGen, Inc. (the "Company") issued a press release announcing the continued adjournment of its 2021 annual meeting of stockholders solely with respect to proposal 2 relating to the approval of an amendment to the Company's Amended and Restated Certificate of Incorporation, as amended, to increase the authorized number of shares of capital stock from 60,000,000 to 110,000,000 shares and authorized number of shares of common stock from 50,000,000 to 100,000,000 shares. The Annual Meeting will reconvene at 10:00 a.m. Eastern Time on August 5, 2021, at the offices of the Company located at 9717 Key West Ave, Suite 100, Rockville, MD 20850. A copy of such press release is attached to this Current Report on Form 8-K as Exhibit 99.1.

Item 9.01 - Financial Statements and Exhibits.

(d) Exhibits

The following exhibits are filed herewith:

99.1 Press release, dated July 7, 2021.

© Edgar Online, source Glimpses

All news about OPGEN, INC.
09/15OPGEN : Announces Data from Prospective Randomized Controlled Multicenter Clinical Study U..
AQ
09/15OpGen, Inc Announces Clinical Data from Investigator-Initiated and Driven Prospective R..
CI
08/13OPGEN : Note 2 - Going Concern and Management's Plans
AQ
08/13OPGEN : Corporate Presentation (PDF)
PU
08/12OPGEN : Reports Second Quarter 2021 Financial Results and Provides Business Update (Form 8..
PU
08/12OPGEN INC : Results of Operations and Financial Condition, Financial Statements and Exhibi..
AQ
08/12Opgen, Inc. Reports Earnings Results for the Second Quarter Ended June 30, 2021
CI
08/12OPGEN : Earnings Flash (OPGN) OPGEN Posts Q2 Revenue $811,615
MT
08/12OPGEN : Reports Second Quarter 2021 Financial Results and Provides Business Update
AQ
08/05OPGEN INC : Other Events, Financial Statements and Exhibits (form 8-K)
AQ
More news
Analyst Recommendations on OPGEN, INC.
More recommendations
Financials (USD)
Sales 2021 3,30 M - -
Net income 2021 -38,5 M - -
Net Debt 2021 7,16 M - -
P/E ratio 2021 -2,92x
Yield 2021 -
Capitalization 117 M 117 M -
EV / Sales 2021 37,5x
EV / Sales 2022 11,5x
Nbr of Employees 102
Free-Float 99,7%
Chart OPGEN, INC.
Duration : Period :
OpGen, Inc. Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends OPGEN, INC.
Short TermMid-TermLong Term
TrendsBullishBullishBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 2
Last Close Price 3,11 $
Average target price 5,00 $
Spread / Average Target 60,8%
EPS Revisions
Managers and Directors
Oliver Schacht Chief Executive Officer & Director
William E. Rhodes Non-Executive Chairman
Vadim Sapiro Chief Information Officer
Faranak Atrzadeh Chief Marketing & Scientific Affairs Officer
Johannes Bacher Chief Operating Officer
Sector and Competitors
1st jan.Capi. (M$)
OPGEN, INC.52.45%119
MODERNA, INC.335.15%183 498
LONZA GROUP AG33.58%61 085
IQVIA HOLDINGS INC.46.38%50 254
CELLTRION, INC.-23.54%33 124
SEAGEN INC.-5.09%30 241